Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans.
The tissue-specific expression of five human pancreatic-type RNases and RNase inhibitor was analyzed by Northern hybridization against poly(A)+ RNA prepared from 16 normal tissues. The widespread expression of RNase 1 was observed in almost all of the tissues. RNase 4 and angiogenin showed a similar distribution of expression abundantly present in the liver. This suggested the identity of the cell types producing these two molecules. However, no relativity appeared to be present between the vascularization of the tissues and the angiogenin expression. A narrow range of expression of the eosinophil-derived neurotoxin gene was observed. This localization seems related to the phagocytic cells in the tissues. The undetectable level of the eosinophil cationic protein mRNA in normal tissues suggests that the differentiation of eosinophils, triggered by inflammation and/or atopy, is required. The expression of RNase inhibitor was found to be ubiquitous. The regulatory function of inhibitor against RNases in the cell should be considered in studying the physiological significance of the pancreatic-type RNase family.
Futami
J
J
Department of Bioengineering Science, Faculty of Engineering, Okayama University, Tsushima-Naka, Japan.
Tsushima
Y
Y
Murato
Y
Y
Tada
H
H
Sasaki
J
J
Seno
M
M
Yamada
H
H
D018076:DNA, Complementary / Q000235:genetics; D004791:Enzyme Inhibitors; D006801:Humans; D010802:Phylogeny; D014176:Protein Biosynthesis; D011506:Proteins / Q000037:antagonists & inhibitors; D012259:Ribonuclease, Pancreatic / Q000037:antagonists & inhibitors* / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D017422:Sequence Analysis, DNA; D014018:Tissue Distribution
D018076:DNA, Complementary; D004791:Enzyme Inhibitors; D011506:Proteins; C046366:angiogenin; D012259:Ribonuclease, Pancreatic